Blood Bank And Plasma Freezer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (2° to 6° and -20° to -40°), By Application (Hospitals, Blood Bank, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 99.41 Million
CAGR (2026-2031)	5.81%
Fastest Growing Segment	-20° to -40°
Largest Market	North America
Market Size (2031)	USD 139.51 Million

Market Overview

The Global Blood Bank And Plasma Freezer Market will grow from USD 99.41 Million in 2025 to USD 139.51 Million by 2031 at a 5.81% CAGR. Blood bank and plasma freezers are specialized refrigeration systems designed to store whole blood, plasma, and blood components at strictly controlled temperatures to ensure biological viability and regulatory compliance. The market is primarily supported by the escalating demand for blood products necessitated by complex surgeries, trauma cases, and the rising prevalence of chronic hematological disorders. Additionally, the extension of healthcare services into emergency mobile settings is bolstering the need for reliable storage infrastructure. According to America's Blood Centers, in 2024, the participation of community blood centers in prehospital blood programs nearly doubled, reflecting this critical expansion in storage requirements.

However, a significant challenge impeding market growth is the high capital and operational cost associated with medical-grade refrigeration. Smaller healthcare facilities often struggle with the financial burden of procuring these energy-intensive units while strictly adhering to biological safety standards. This economic constraint, coupled with the technical demands of maintaining precise temperature uniformity to prevent spoilage, limits the broader adoption of these essential storage solutions in resource-constrained environments.

Key Market Drivers

The escalating prevalence of chronic diseases is a primary catalyst propelling the demand for reliable cold storage solutions. As the incidence of hematological malignancies rises, the requirement for transfusion therapies increases, necessitating the long-term preservation of whole blood and red blood cells in compliant refrigeration units. This trend forces hospitals to upgrade storage capacities to manage higher inventory turnover and prevent the spoilage of life-saving biological material. According to the American Cancer Society, January 2024, in the 'Cancer Facts & Figures 2024', new cancer cases in the United States were projected to surpass the 2 million mark for the first time, underscoring the intensifying pressure on blood banking infrastructure to support oncological care.

Concurrently, the burgeoning sector of plasma-derived biopharmaceuticals is significantly expanding the utility of plasma freezers. Pharmaceutical companies are scaling operations to meet therapeutic needs for immunodeficiencies, requiring the rapid freezing of source plasma at ultra-low temperatures to maintain protein integrity. This industrial scale-up directly correlates with procurement orders for high-capacity, medical-grade freezers capable of maintaining stable thermal environments. According to Takeda, May 2024, in the 'Full Year 2023 Financial Results', the company reported that its plasma supply volume increased by approximately 14% year-on-year, reflecting the aggressive expansion of collection activities. The scarcity of these resources further amplifies the need for efficient storage; according to the American Red Cross, in 2024, the number of people donating blood reached a 20-year low, necessitating the optimal preservation of every collected unit.

Download Free Sample Report

Key Market Challenges

The high capital and operational costs associated with medical-grade refrigeration constitute a formidable barrier to the expansion of the Global Blood Bank and Plasma Freezer Market. Unlike standard refrigeration, these specialized units require advanced engineering to maintain strict temperature uniformity and fail-safe reliability, significantly driving up their initial procurement price. This presents a substantial hurdle for budget-constrained healthcare institutions, particularly smaller community hospitals and rural clinics that often operate on thin financial margins. The ongoing expense of energy consumption and maintenance further exacerbates this burden, forcing facilities to prioritize immediate clinical supplies over infrastructure investments.

Consequently, this financial strain directly restricts market volume as institutions are compelled to defer the replacement of aging equipment or forego expansion. According to the American Hospital Association, in 2025, 94 percent of health care administrators expected to delay equipment upgrades to manage financial strain. This widespread hesitation to invest in new technology slows the adoption rate of modern freezer systems, regardless of the growing clinical need for storage capacity. As a result, the market experiences dampened growth momentum in regions where healthcare funding cannot keep pace with the rising costs of essential medical hardware.

Key Market Trends

The Transition to Sustainable Low-GWP Natural Refrigerants is significantly reshaping the market as manufacturers prioritize environmental compliance and operational cost reduction. This trend is driven by stringent regulations phasing out hydrofluorocarbons (HFCs) and the critical need for energy-efficient mechanisms within power-intensive medical cold chains. Modern units now integrate hydrocarbon-based cooling systems and variable speed compressors to minimize ecological footprints while maintaining precise thermal stability for sensitive biological materials. According to Haier Biomedical, November 2025, in the 'HB At MEDICA 2025: Defining Future With Four Smart Solutions' press release, their UltraEco ULT Freezer achieved a daily energy consumption of just 4.16 kWh, topping U.S. ENERGY STAR rankings and reducing annual carbon emissions by approximately 2,269 kg compared to traditional models.

Simultaneously, the Implementation of Automated Robotic Sample Retrieval Solutions is gaining traction to address the complexities of managing massive biobank and plasma inventories. High-volume biorepositories are increasingly adopting automated, high-density storage systems to eliminate human error, reduce frost exposure during retrieval events, and significantly increase operational throughput. This technology ensures sample integrity by limiting ambient air exposure and streamlines the tracking of millions of distinct biological specimens. According to Azenta, Inc., January 2025, in the press release 'UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence', the organization's new automated infrastructure expands storage capacity by 16 million samples and supports a high-speed retrieval capability of up to 9 million picks per year.

Segmental Insights

The -20°C to -40°C segment is rapidly emerging as the fastest-growing category within the global blood bank and plasma freezer market. This expansion is primarily driven by the critical necessity of storing Fresh Frozen Plasma (FFP) in strict compliance with safety standards established by the AABB. These guidelines mandate maintaining deep-freeze environments to effectively preserve labile clotting factors, particularly Factor VIII, which are susceptible to degradation. As the global demand for plasma-derived therapies increases, healthcare facilities are prioritizing investments in equipment within this temperature range to ensure therapeutic viability and regulatory adherence.

Regional Insights

North America dominates the Global Blood Bank And Plasma Freezer Market, driven by its expansive healthcare infrastructure and rigorous regulatory frameworks. The region’s market position is reinforced by strict adherence to safety standards from the U.S. Food and Drug Administration (FDA) and the AABB, which necessitates the use of reliable, compliant storage systems. Additionally, the high prevalence of chronic conditions and a robust biopharmaceutical sector fuel steady demand for plasma preservation. These factors collectively ensure the region’s sustained leadership in the global landscape, supported by continuous investments in medical safety and research.

Recent Developments

• In January 2025, Stirling Ultracold announced the commercial release of the VAULT100, a new upright ultra-low temperature freezer designed to enhance sample integrity in the life sciences market. The unit features a unique temperature range of -100 degrees Celsius to -20 degrees Celsius, powered by a robust free-piston Stirling engine that improves energy efficiency and reliability compared to standard compressor-based models. The freezer includes a large touchscreen interface with onboard predictive analytics, allowing operators to monitor system health proactively. The Chief Executive Officer of the company highlighted that the wider temperature range and tighter control were developed to meet the rigorous storage requirements of modern laboratories and biobanking facilities.
• In April 2024, Thermo Fisher Scientific launched its TSX Universal Series of ultra-low temperature freezers, which included medical device units specifically engineered to store and preserve blood and blood products. These freezers utilize Universal V-Drive technology to offer tighter control and faster recovery times, operating at freezing temperatures between -40 degrees Celsius and -86 degrees Celsius. The launch marked a significant advancement for users in Good Manufacturing Practice (GMP) environments, as the units obtained an ISO Class 5.5 cleanroom designation. This certification provided cell and gene therapy customers with enhanced confidence in the cleanliness and stability of their storage environments for critical biological materials.
• In February 2024, PHC Corporation of North America announced the launch of a new dual-voltage model within its PHCbi brand VIP ECO SMART ultra-low temperature freezer series. The newly introduced MDF-DU703VHA-PA unit was designed to provide critical flexibility for medical institutions and universities by allowing laboratories to switch between 115V and 220V power sources with a simple power cord change. This development addressed the common challenge of matching laboratory equipment to available voltage outputs while maintaining energy-efficient performance. The freezer utilizes natural refrigerants and inverter compressor technology to minimize power consumption, supporting the precise preservation of biological samples such as cells and plasma.
• In January 2024, Haier Biomedical secured a significant tender to supply over 300 units of blood bank refrigerators to the Ministry of Health in Tanzania. This initiative was part of a national public health project aimed at equipping new hospitals throughout the country with reliable cold chain infrastructure. The company provided its HXC-158 model, which features precision temperature control to maintain internal fluctuations within ±1 degree Celsius, ensuring the safety of stored blood products. These units are designed with built-in batteries to display temperature data for up to 48 hours during power outages, addressing the region's need for secure storage solutions in areas with unstable power supplies.

Key Market Players

• Biobase Biodusty(Shandong), Co., Ltd.
• Fiocchetti Scientific S.R.L.
• Infitek Co., Ltd.
• Zhongke Meiling Cryogenics Co.,Ltd
• Newtronic Lifecare Equipment Pvt Ltd
• NuAire, Inc
• Thermo Fisher Scientific Inc.
• Synnovis Group LLP
• F. Hoffmann-La Roche Ltd.
• Beckman Coulter, Inc.

By Type	By Application	By Region
2° to 6° and -20° to -40°	Hospitals Blood Bank Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Blood Bank And Plasma Freezer Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Blood Bank And Plasma Freezer Market, By Type:

• 2° to 6° and -20° to -40°

• Blood Bank And Plasma Freezer Market, By Application:

• Hospitals
• Blood Bank
• Others

• Blood Bank And Plasma Freezer Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE